Savient acquired by Crealta Pharmaceuticals in $120M bankruptcy auct...

12/11/13


Drug Discovery & Development

Savient acquired by Crealta Pharmaceuticals in $120M bankruptcy auction
NJBIZ
The Bridgewater-based Savient announced in mid-October its Chapter 11 bankruptcy filing, in which it agreed to sell its assets for $55 million to WorldMeds subsidiary Sloan Holdings C.V. That agreement set the floor for a bankruptcy auction resulting ...
Savient Pharma plans asset sale to CrealtaBusinessweek
Savient Agrees to Sell Itself to Crealta for $120.4 MillionWall Street Journal
Savient attracts a buyer willing to get it out of bankruptcy courtFiercePharma
The Wall Street Transcript -StreetInsider.com (subscription)
all 15 news articles »

[more]